Atlas Trials

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Clinical trial NCT00060645 · COMPLETED

Trial details

NCT number
NCT00060645
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
TumorsLymphomaMultiple Myeloma
Start date
2003-05-01
Primary completion
2006-05-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.